文献速递内脏/肾动脉与血管畸形

全院性直接穿刺栓塞治疗外周静脉畸形的算法

An institution-wide algorithm for direct-stick embolization of peripheral venous malformations.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2018-02-01

本文介绍了一个全院性算法,用于使用单一栓塞治疗方式——直接穿刺栓塞(DSE)——管理有症状的先天性外周静脉畸形(VMs)。在36个月内,40例患者接受了71次DSE,使用1%和3%的十四烷基硫酸钠(STS)液体,大多数患者(65%)单次治疗即完全缓解症状,但发生一例术后死亡(1.4%)继发于大面积肺栓塞。作者结论认为,在没有过敏反应的情况下,大多数先天性外周VMs可安全地用液体STS栓塞,避免乙醇的已知毒性,但静脉血栓栓塞仍是主要致病和致死原因,需要前瞻性随机试验来标准化栓塞治疗。

要点

  • 65%的患者单次DSE即完全缓解症状,35%需要重复DSE。
  • 术后死亡1例(1.4%),继发于大面积肺栓塞;并发症还包括皮肤坏死2例(3%)。
  • 作者认为,在没有过敏反应的情况下,大多数先天性外周VMs可安全地用液体STS栓塞,避免乙醇的已知毒性。

核心结论

  • 作者结论认为,在没有过敏反应的情况下,大多数先天性外周VMs可安全地用液体STS栓塞,从而避免乙醇的已知毒性;静脉血栓栓塞仍是该患者人群的主要致病和致死原因,尽管进行了密切的血液学监测;需要前瞻性随机试验来实现栓塞治疗的标准化。

研究设计与样本

  • 单中心、单操作者的前瞻性数据收集并回顾性分析,纳入36个月内40例有症状的先天性外周VMs患者,共进行71次直接穿刺栓塞(DSE),平均随访17.1个月(范围0.8-31.6个月)。

主要发现

  • 40例患者(12例男性;平均年龄22岁,范围2-53岁)接受了71次DSE(每例平均1.8次,范围1-8次)。
  • 症状包括疼痛40例(100%)、肿胀36例(90%)、美容畸形32例(80%)。
  • 解剖分布:上肢16例(23%)、下肢37例(52%)、头颈部7例(10%)、躯干10例(14%)、内脏1例(1%)。
  • 26例(65%)单次DSE即完全缓解症状,14例(35%)需要重复DSE,2例(5%)需要辅助手术切除。
  • 术后死亡1例(1.4%)继发于大面积肺栓塞;并发症还包括皮肤坏死2例(3%)。每次治疗平均硬化剂体积为1% STS 7 mL(范围3-14 mL)和3% STS 15 mL(范围3-42.5 mL)。

关键数值与推荐

  • 使用1%和3%两种浓度的十四烷基硫酸钠(STS;Sotradecol;AngioDynamics,Latham,NY)进行直接穿刺栓塞,不制备泡沫。
  • 4例患者存在局限性血管内凝血,其中2例需要围手术期依诺肝素。
  • 如果发现浅静脉反流,在初次栓塞前或同时按标准方案进行射频消融。

临床怎么用

  • 本研究中心的做法是:对有症状的先天性外周VMs患者进行对比增强磁共振成像,所有患者进行局限性血管内凝血的血液学监测并据此给予围手术期抗凝,适用时进行静脉双功超声评估深静脉系统存在和通畅性及浅静脉反流,如发现浅静脉反流则按标准方案在初次栓塞前或同时进行射频消融,然后由单一操作者使用1%和3% STS液体进行直接穿刺栓塞。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: No standardized therapeutic algorithm or embolic agent of choice has yet been identified for management of congenital peripheral venous malformations (VMs). Treatment options and reported outcomes therefore vary widely. Herein, we present an institution-wide algorithm for management of symptomatic congenital peripheral VMs using a single embolotherapeutic modality. METHODS: During 36 months, patients with symptomatic congenital peripheral VMs underwent contrast-enhanced magnetic resonance imaging. Hematologic monitoring for localized intravascular coagulopathy was performed in all. Perioperative anticoagulation was administered accordingly. When applicable, venous duplex ultrasound was performed to assess for presence and patency of a deep venous system and superficial venous reflux. If superficial venous reflux was identified, radiofrequency ablation was performed per standard protocol before or at the time of initial embolization. Direct-stick embolizations (DSEs) were performed by a single operator using two concentrations (1% and 3%) of sodium tetradecyl sulfate (STS; Sotradecol; AngioDynamics, Latham, NY) without foam preparation. Patients were followed up clinically for resolution of symptoms, coagulopathic monitoring, and development of complications. All data were prospectively maintained and retrospectively reviewed. RESULTS: There were 71 DSEs performed in 40 patients (1.8 procedures per patient [range, 1-8]; 12 male patients; mean age, 22 years [range, 2-53 years]). Mean follow-up was 17.1 months (range, 0.8-31.6 months). Presenting symptoms included pain (n = 40 [100%]), swelling (n = 36 [90%]), and cosmetic disfigurement (n = 32 [80%]). Anatomic distribution was upper extremity (n = 16 [23%]), lower extremity (n = 37 [52%]), head and neck (n = 7 [10%]), trunk (n = 10 [14%]), and visceral (n = 1 [1%]). There were 33 sporadic cases, 4 (10%) Klippel-Trénaunay syndrome cases, 2 (5%) blue rubber bleb nevus syndrome cases, and 1 (2.5%) CLOVES (congenital lipomatous overgrowth, vascular malformations, epidermal nevus, and skeletal deformities) syndrome case. Four patients presented with localized intravascular coagulopathy, two of whom required perioperative enoxaparin. Twenty-six patients (65%) required a single DSE session with complete symptom relief. Fourteen patients (35%) required repeated DSE. Two patients (5%) required adjunctive surgical excision. There was one postoperative death (1.4%) secondary to massive pulmonary embolism. Complications were otherwise limited to skin necrosis (n = 2 [3%]). Mean volume of sclerosant per session was 7 mL of 1% STS (range, 3-14 mL), and 15 mL of 3% STS (range, 3-42.5 mL). CONCLUSIONS: In the absence of allergic reactions, most congenital peripheral VMs can be safely embolized with liquid STS, thereby avoiding the well-documented toxicity of ethanol. Venous thromboembolism remains a major source of morbidity and mortality in this population of patients despite close hematologic scrutiny. Prospective randomized trials are needed for embolotherapeutic standardization.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Nassiri N, Huntress LA, Simon M, et al. An institution-wide algorithm for direct-stick embolization of peripheral venous malformations. J Vasc Surg Venous Lymphat Disord. 2018. PMID: 29396158. doi:10.1016/j.jvsv.2017.12.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。